Type Whole antibody Target HGF CAS Number 1188277-05-5 | Source Human ATC code none ChemSpider none | |
Flanvotumab, also known as IMC-20D7S, is a human monoclonal antibody designed for the treatment of melanoma. It targets TYRP1.
Flanvotumab was developed by ImClone Systems, now owned by Eli Lilly.
References
Flanvotumab Wikipedia(Text) CC BY-SA